Osimertinib
Related papers: 2
Top Researchers
Top Cited Papers
81MO Osimertinib as neoadjuvant therapy in patients with EGFR mutated resectable stage II-IIIB lung adenocarcinoma (NEOS): Updated results
Chuhl Joo Lyu, Wentao Fang, Weiqi Jiao, Haitao Ma, J. Wang, S. Xu, Nan Wu, R. Wang, Yongbo Yang
Citations: 10 • 2022
Response to osimertinib in a colorectal cancer patient with an <i>EGFR</i> T790M mutation: A case report
Blake Buzard, Lindsey Douglass, Beth Gustafson, Jennifer Buckley, Marc Roth, Lara Kujtan, Dhruv Bansal
Citations: 9 • 2023